Eton Pharmaceuticals, Inc.
General ticker "ETON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $606.9M (TTM average)
Eton Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 43.9%.
Estimated limits based on current volatility of 3.1%: low 51.01$, high 54.30$
Factors to consider:
- Total employees count: 44 (+41.9%) as of 2025
- Top business risk factors: Inflation reduction act impact, Pricing and reimbursement, Third-party risks, Supply chain disruptions, Regulatory and compliance
- Current price 98.5% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [15.04$, 25.34$]
- 2026-12-31 to 2027-12-31 estimated range: [15.15$, 25.63$]
Financial Metrics affecting the ETON estimates:
- Positive: with PPE of -335.5 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 2.33 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -1.04
- Positive: 25.20 < Shareholder equity ratio, % of 28.39 <= 34.41
- Positive: -0.14 < Investing cash flow per share per price, % of -0.07
Short-term ETON quotes
Long-term ETON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $31.64MM | $39.01MM | $79.95MM |
| Operating Expenses | $32.83MM | $41.61MM | $80.79MM |
| Operating Income | $-1.19MM | $-2.60MM | $-0.84MM |
| Non-Operating Income | $0.50MM | $-1.21MM | $-3.71MM |
| R&D Expense | $3.32MM | $3.25MM | $7.76MM |
| Income(Loss) | $-0.69MM | $-3.81MM | $-4.56MM |
| Taxes | $0.25MM | $0.01MM | $0.04MM |
| Net Income(Loss)* | $-0.94MM | $-3.82MM | $-4.60MM |
| Stockholders Equity | $15.48MM | $24.43MM | $26.15MM |
| Inventory | $0.91MM | $15.23MM | $15.42MM |
| Assets | $31.74MM | $76.12MM | $92.11MM |
| Operating Cash Flow | $6.82MM | $0.97MM | $10.52MM |
| Capital expenditure | $0.78MM | $0.03MM | $0.33MM |
| Investing Cash Flow | $-0.78MM | $-40.01MM | $-0.33MM |
| Financing Cash Flow | $-0.96MM | $32.59MM | $0.81MM |
| Earnings Per Share** | $-0.04 | $-0.15 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.